# CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI

> **NCT03296540** · PHASE4 · COMPLETED · sponsor: **Maasstad Hospital** · enrollment: 729 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** Prasugrel (Crushed tablets)
- **DRUG:** Prasugrel (Integral tablets)

## Key facts

- **NCT ID:** NCT03296540
- **Lead sponsor:** Maasstad Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-28
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-05-01
- **Target enrollment:** 729 (ACTUAL)
- **Last updated:** 2021-05-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03296540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03296540, "CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03296540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*